India 3d Printed Drugs Market Size & Outlook, 2023-2030
India 3d printed drugs market, 2018-2030 (US$M)
Related Markets
India 3d printed drugs market highlights
- The India 3d printed drugs market generated a revenue of USD 0.8 million in 2023 and is expected to reach USD 2.9 million by 2030.
- The India market is expected to grow at a CAGR of 19.6% from 2024 to 2030.
- In terms of segment, neurology was the largest revenue generating application in 2023.
- Neurology is the most lucrative application segment registering the fastest growth during the forecast period.
3d printed drugs market data book summary
| Market revenue in 2023 | USD 0.8 million |
| Market revenue in 2030 | USD 2.9 million |
| Growth rate | 19.6% (CAGR from 2023 to 2030) |
| Largest segment | Neurology |
| Fastest growing segment | Neurology |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Dental, Orthopedic, Neurology |
| Key market players worldwide | GlaxoSmithKline, Hewlett Packard Enterprise Co, Merck KGaA, AstraZeneca PLC, Aprecia Pharmaceuticals, Extend Biosciences, BioDuro, Affini-T Therapeutics, Osmotica Pharmaceutical, FabRx, Cycle Pharmaceuticals |
Other key industry trends
- In terms of revenue, India accounted for 0.8% of the global 3d printed drugs market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan 3d printed drugs market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 2.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
3D Printed Drugs Market Scope
3D Printed Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
India 3d printed drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to 3d printed drugs market will help companies and investors design strategic landscapes.
Neurology was the largest segment with a revenue share of 50% in 2023. Horizon Databook has segmented the India 3d printed drugs market based on dental, orthopedic, neurology covering the revenue growth of each sub-segment from 2018 to 2030.
India's 3D printed drugs market is witnessing notable growth, driven by several factors fostering a conducive environment for innovation & development. One significant driver is the growing focus on R&D in 3D printed drugs, with increased investment in cutting-edge technologies & methodologies. The growing R&D initiatives are attracting domestic and international players, further fueling the growth of the India 3D printed drugs market.
Furthermore, India's rapidly aging population and the increasing prevalence of chronic diseases have created a pressing need for cutting-edge medical technologies such as 3D printing, which is expected to support the production of personalized medicine. Furthermore, the government's initiatives to promote innovation, research, and technology adoption in the healthcare sector, along with a thriving startup ecosystem, are propelling the growth of 3D printed drugs.
Reasons to subscribe to India 3d printed drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of India 3d printed drugs market databook
-
Our clientele includes a mix of 3d printed drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the India 3d printed drugs market , including forecasts for subscribers. This country databook contains high-level insights into India 3d printed drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
India 3d printed drugs market size, by application, 2018-2030 (US$M)
India 3D Printed Drugs Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
